首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝门部胆管癌的外科治疗
引用本文:葛步军,范跃组.肝门部胆管癌的外科治疗[J].山西医科大学学报,2005,36(5):609-611.
作者姓名:葛步军  范跃组
作者单位:同济大学附属同济医院外科,上海,200065
摘    要:目的探讨肝门部胆管癌不同外科治疗方法间的疗效差异。方法回顾总结2000~2004年手术治疗的肝门部胆管癌的临床资料。结果34例中手术切除18例,切除率52.94%,其中根治性切除率为44.44%,切除组与引流组的平均生存期分别为16.7个月与7.8个月,二者疗效差异有显著意义P<0.05。结论肝门部胆管癌应争取手术切除,减黄措施应首选手术内引流。

关 键 词:胆管肿瘤  外科手术  预后
文章编号:1007-6611(2005)05-0609-03
收稿时间:2005-01-17
修稿时间:2005年1月17日

Surgical treatment for hilar cholangiocarcinoma
GE Bu-jun,FAN Yue-zu.Surgical treatment for hilar cholangiocarcinoma[J].Journal of Shanxi Medical University,2005,36(5):609-611.
Authors:GE Bu-jun  FAN Yue-zu
Institution:Dept of Surgery, Tongji Hospital, Tongji University, Shanghai 200065, China
Abstract:Objective To explore the difference of therapeutic effects of different surgical treatments for hilar cholangiocarcinoma.Method Clinical data of 34 patients with hilar cholangiocarcinoma treated surgically were analysed retrospectively. Results Of the 34 patients,18 underwent resection.The total resection rate was 52.94% and the radical resection rate 44.44%.The mean survival time was 16.7 months for those who underwent resection and 7.8 months for those who did not(P<0.05).There was significant difference between resection group and drainage group.Conclusion Surgical resection is still the choice for the treatment of hilar cholangiocarcinoma,and the best way to reduce jaundice is internal drainage surgically.
Keywords:bile duct neoplasms  surgical procedures  operative  prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号